Profile data is unavailable for this security.
About the company
EXCELSIOR MEDICAL CO., LTD. is a Taiwan-based company principally engaged in the distribution, maintenance and leasing of medical equipment and supplies. The Company’s principal products include artificial kidneys, hemodialysis blood tubing sets and epidural needles, dialysis liquid medicines and powder medicines, dialysis machines, human erythropoietin, surgery consumable materials, blood bags, plasma replacement machines and beauty medical equipment, among others. The Company is also involved in the production and sales of self-owned soybean milk machines, as well as household air fresheners under the brand name of Coway. The Company mainly operates its businesses in domestic market and overseas markets.
- Revenue in TWD (TTM)8.27bn
- Net income in TWD729.96m
- Incorporated1988
- Employees774.00
- LocationExcelsior Medical Co Ltd17F, No.880Jhongjheng RoadJhonghe DistrictNEW TAIPEI 235TaiwanTWN
- Phone+886 222251888
- Fax+886 222212488
- Websitehttps://www.excelsiormedical.com.tw/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CHC Healthcare Group | 3.73bn | 341.88m | 8.77bn | 160.00 | 28.35 | 1.42 | 9.51 | 2.35 | 1.86 | 1.86 | 19.97 | 36.92 | 0.2753 | 4.08 | 3.97 | -- | 2.52 | 3.23 | 3.00 | 3.80 | 26.37 | 30.12 | 9.15 | 13.16 | 2.01 | 10.78 | 0.455 | 81.75 | 30.35 | 9.11 | 17.47 | 5.31 | 9.69 | 2.25 |
| SciVision Biotech Inc | 787.96m | 196.83m | 8.95bn | 64.00 | 48.98 | 5.78 | 34.40 | 11.35 | 2.67 | 2.67 | 10.33 | 22.67 | 0.3601 | 2.14 | 8.34 | -- | 9.00 | 6.67 | 10.09 | 7.41 | 74.13 | 69.94 | 24.98 | 25.00 | 2.90 | -- | 0.1739 | 79.74 | 27.93 | 16.69 | 25.53 | 15.41 | -31.16 | 12.22 |
| Excelsior Medical Co Ltd | 8.27bn | 729.96m | 14.02bn | 774.00 | 19.27 | 1.68 | 12.07 | 1.70 | 4.67 | 4.67 | 52.96 | 53.65 | 0.4706 | 5.36 | 5.48 | -- | 5.14 | 4.94 | 10.49 | 9.25 | 20.25 | 20.22 | 10.91 | 10.60 | 1.28 | -- | 0.0914 | 83.22 | 14.56 | 5.35 | 11.86 | 10.58 | 31.53 | 7.24 |
| Vizionfocus Inc | 2.83bn | 654.83m | 16.71bn | -- | 23.92 | 5.22 | 15.90 | 5.90 | 12.14 | 12.14 | 52.60 | 55.63 | 0.6401 | 6.99 | 6.07 | -- | 17.03 | 12.00 | 22.00 | 16.54 | 40.90 | 37.01 | 26.60 | 20.52 | 2.90 | -- | 0.2795 | 28.73 | 40.23 | 52.18 | 79.65 | 233.89 | 71.42 | -- |
| Visco Vision Inc | 2.69bn | 432.93m | 17.55bn | -- | 40.60 | 5.87 | 21.07 | 6.53 | 6.86 | 6.86 | 42.60 | 47.46 | 0.5397 | 2.85 | 5.99 | -- | 8.56 | 11.68 | 11.17 | 15.80 | 39.40 | 40.56 | 15.86 | 17.72 | 1.16 | 21.32 | 0.2707 | 43.00 | -13.68 | 25.82 | -51.15 | 8.74 | 0.8293 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 06 Jun 2024 | 2.47m | 1.59% |
| Acadian Asset Management LLCas of 30 Sep 2023 | 237.76k | 0.15% |
| SSgA Funds Management, Inc.as of 06 Jun 2024 | 190.73k | 0.12% |
| American Century Investment Management, Inc.as of 06 Jun 2024 | 139.50k | 0.09% |
| Dimensional Fund Advisors Ltd.as of 30 Apr 2024 | 130.12k | 0.08% |
| DFA Australia Ltd.as of 31 May 2024 | 67.08k | 0.04% |
| FIL Investments Internationalas of 30 Jun 2023 | 1.85k | 0.00% |
| LGT Capital Partners AG (Investment Management)as of 30 Nov 2023 | 0.00 | 0.00% |
